|
Volumn 65, Issue 5, 2017, Pages 1765-1768
|
Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ENTECAVIR;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
TENOFOVIR DISOPROXIL;
VIRUS DNA;
ANTIVIRUS AGENT;
ABDOMINAL DISCOMFORT;
ADULT;
ANTIVIRAL THERAPY;
ARTICLE;
CASE CONTROL STUDY;
CHRONIC HEPATITIS B;
CLINICAL ARTICLE;
CONSTIPATION;
CONTROLLED STUDY;
DIARRHEA;
FECAL MICROBIOTA TRANSPLANTATION;
FEMALE;
FOLLOW UP;
HUMAN;
LIMIT OF DETECTION;
LONG TERM CARE;
MALE;
OPEN STUDY;
PILOT STUDY;
PRIORITY JOURNAL;
IMMUNOLOGY;
INTESTINE FLORA;
VIROLOGY;
ADULT;
ANTIVIRAL AGENTS;
CASE-CONTROL STUDIES;
FECAL MICROBIOTA TRANSPLANTATION;
FEMALE;
GASTROINTESTINAL MICROBIOME;
HEPATITIS B E ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
MALE;
|
EID: 85015729797
PISSN: 02709139
EISSN: 15273350
Source Type: Journal
DOI: 10.1002/hep.29008 Document Type: Article |
Times cited : (132)
|
References (5)
|